Evaluation of Standard versus Enhanced Bilateral Lateral Rectus Recession Techniques for Intermittent Exotropia

• by Ji Woong Chang

• January 8, 2026

FDA Approves New Treatment for Thyroid Eye Disease

Phase 3 THRIVE and THRIVE-2 trials supported approval following improvements in proptosis and diplopia in active and chronic disease.

• by Kathryn Wighton

• June 29, 2026

• 3 min

The Gut Microbiome and Butyrate Differentiate Clostridioides difficile Colonization and Infection in Children

• by Maribeth R Nicholson, Siyuan Ma, Britton A Strickland, Mia Cecala, Lisa Zhang, Seth Reasoner, Emma R Guiberson, Matthew J Munneke, Meghan H Shilts, Eric P Skaar, Suman R Das

• December 11, 2025

Diagnostic Accuracy of a Retinal Birefringence Scanning Device Compared With a Traditional Autorefraction

• by Julius T. Oatts, Patrick Takla, Ha-Neul Yu, Natan Hekmatjah, Maanasa Indaram, Jocelyn He, Gui-Shuang Ying, Jeremy D. Keenan

• July 1, 2026